Clinical and molecular features of Epidermal Growth Factor Receptor (EGFR) mutation positive non-small-cell lung cancer patients treated with tyrosine kinase inhibitors: predictive and prognostic role of co-mutations(2021 Jul 09).
Clinical and molecular features of Epidermal Growth Factor Receptor (EGFR) mutation positive non-small-cell lung cancer patients treated with tyrosine kinase inhibitors: predictive and prognostic role of co-mutations
BIRONZO, Paolo
2021-07-09
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Bironzo_PhD-Thesis_first revised after reviewers comments.pdf
Accesso aperto
Descrizione: Tesi
Dimensione
1.03 MB
Formato
Adobe PDF
|
1.03 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
